Taisho Pharmaceutical News
Most Popular Taisho Pharmaceutical Story
BMS deal pushes Taisho in Asia
Japan's Taisho Pharmaceutical is spending $310 million to further assert itself as a prominent Asian drug maker. The company is buying the Asian rights for some Bristol-Myers Squibb over-the-counter Read more...
Latest Headlines
- September 16, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
